Liposomal formulation of a methotrexate lipophilic prodrug: assessment in tumor cells and mouse T-cell leukemic lymphoma
Anna A Alekseeva,1 Ekaterina V Moiseeva,1 Natalia R Onishchenko,1 Ivan A Boldyrev,1 Alexander S Singin,2,† Andrey P Budko,2 Zoya S Shprakh,2 Julian G Molotkovsky,1 Elena L Vodovozova1 1M.M. Shemyakin and Yu.A. Ovchinnikov Institute of Bioorganic Chemistry of the Russian Academy of Scienc...
Guardado en:
Autores principales: | Alekseeva AA, Moiseeva EV, Onishchenko NR, Boldyrev IA, Singin AS, Budko AP, Shprakh ZS, Molotkovsky JG, Vodovozova EL |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/35d451080f024fab83112a996cf37289 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Liposomal formulation of a methotrexate lipophilic prodrug: assessment in tumor cells and mouse T-cell leukemic lymphoma [Corrigendum]
por: Alekseeva AS, et al.
Publicado: (2017) -
Novel lipophilic SN38 prodrug forming stable liposomes for colorectal carcinoma therapy
por: Xing J, et al.
Publicado: (2019) -
Novel SN38 derivative-based liposome as anticancer prodrug: an in vitro and in vivo study
por: Wu C, et al.
Publicado: (2018) -
A Comparative Study of the Lipophilicity of Metformin and Phenformin
por: Małgorzata Dołowy, et al.
Publicado: (2021) -
Design of pH-sensitive methotrexate prodrug-targeted curcumin nanoparticles for efficient dual-drug delivery and combination cancer therapy
por: Xie JJ, et al.
Publicado: (2018)